Skip to main content

Peer Review reports

From: Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report

Original Submission
1 Nov 2022 Submitted Original manuscript
7 Jan 2023 Reviewed Reviewer Report
8 Jan 2023 Reviewed Reviewer Report
25 Jan 2023 Reviewed Reviewer Report
24 Feb 2023 Author responded Author comments - Ippei Miyamoto
Resubmission - Version 2
24 Feb 2023 Submitted Manuscript version 2
12 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
13 Apr 2023 Editorially accepted
8 May 2023 Article published 10.1186/s12890-023-02446-z

You can find further information about peer review here.

Back to article page